Skip to main content
01942 271 746
Apply Online

Portfolio Company Spotlight: Alderley Lighthouse Labs

General News

Portfolio Company Spotlight: Alderley Lighthouse Labs

Posted on 16th January 2023 by

Seneca Growth Capital VCT invested £500k into Alderley Lighthouse Labs (“ALL”) in October 2022.

ALL is a new diagnostics company, set up by two of the leadership team that built the Alderley Park COVID screening laboratory. They have captured many learnings from the pandemic and invested in the latest technologies to offer high quality testing that can be seamlessly integrated with modern IT systems. The company offers services that cover both blood sciences and molecular testing across a broad range of diagnostics including, blood biomarker testing, full blood count, health and fitness markers, diabetes, cancer, infection etc. The laboratory is fully accredited with UKAS to their 15189 standard.

Watch the ALL video on LinkedIn to find out more.

Related Posts

Contact Us

Online form

If you have any questions about anything you’ve seen on our website then please get in touch. We are here to help. Normal office hours are weekdays 9.00am to 5.00pm. The office is not open on weekends or bank holidays.
  • Hidden

  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.

Or via phone or email on

01942 271 746

Please Note

The contents of this website are a financial promotion and are approved by Seneca Partners Limited of 9 The Parks, Newton-le-Willows WA12 0JQ.

The value of an investment in the Seneca Capital Growth VCT plc may go down as well as up, in which case an investor may not get back the amount invested. The share prices quoted may not reflect the VCT’s net asset value.

Seneca Growth Capital VCT plc’s investments include holdings in private companies which are small and which carry an above-average level of risk to capital and whose shares may not be readily marketable. It also invests in companies quoted on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) which is generally for smaller, emerging companies and carries a higher level of risk to capital than the main market of the LSE.  The past performance of Seneca Growth Capital VCT plc is not a guide to the future performance.

Any tax reliefs available to investors are dependent on personal circumstances and may change in the future. The tax reliefs available to certain investors in Seneca Growth Capital VCT plc are dependent on the VCT maintaining Inland Revenue approval. If this approval is withdrawn, the VCT will lose its status and all tax reliefs are likely to be cancelled. Investors must retain their VCT shares for five years to retain the up-front income tax relief. The tax rules and regulations governing VCTs are subject to change.

An investment in Seneca Growth Capital VCT plc may not be suitable for all investors. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Seneca Partners Ltd is authorised and regulated by the Financial Conduct Authority.

Continue to site